摘要

Integrated data from three double-blind, randomized, placebo-controlled trials were analyzed to evaluate the efficacy and tolerability of ezogabine (EZG; US adopted name)/retigabine (RTG; international non-proprietary name) when used in combination with >= 1 sodium channel blocking antiepileptic drug (AED), >= 1 non-sodium channel blocking AED, or >= 1 AED from both the sodium channel and non-sodium channel mechanistic groups. Efficacy and tolerability appeared to be similar across all three groups of patients.

  • 出版日期2014-7